5-Year POSITIVE Data Reassure on Pregnancy in Breast Cancer

Originally published by our sister publication Clinical Oncology NewsBy Jennifer KulpaTemporary interruption of adjuvant endocrine therapy to attempt pregnancy in young women with hormone receptor (HR)-positive early breast cancer was not associated with excess breast cancer events at five years in the POSITIVE trial, according to updated data presented at the 2026 Miami Breast Cancer Conference. The findings extend the original three-year analysis and provide more mature evidence for counseling